Literature DB >> 23138324

Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients.

Dietje E Fransen van de Putte1, Kathelijn Fischer, Michael Makris, R Campbell Tait, Pratima Chowdary, Peter W Collins, Karina Meijer, Goris Roosendaal, Roger E G Schutgens, Eveline P Mauser-Bunschoten.   

Abstract

Cardiovascular disease (CVD) mortality is reported to be decreased in haemophilia patients, but reports on the prevalence of CVD risk factors are conflicting. A cross-sectional assessment of CVD risk profiles was performed in a large cohort of haemophilia patients. Baseline data on CVD risk factors of 709 Dutch and UK haemophilia patients aged ≥30 years were analysed and compared with the general age-matched male population. CVD risk profiles were assessed using the QRISK®2-2011 and SCORE algorithms. Although QRISK® 2 was only validated in the UK, comparison with SCORE indicated similar properties of QRISK®2 in both Dutch and UK patients (correlation 0.86). Mean age was 49.8 years. Hypertension was more common in haemophilia patients than in the general population (49% vs. 40%), while the prevalences of obesity and hypercholesterolaemia were lower (15 vs. 20% and 44 vs. 68%, respectively), and those of diabetes and smoking were similar. The predicted 10-year QRISK®2 risk was significantly higher in haemophilia patients than in the general population (8.9 vs. 6.7%), indicating more unfavourable cardiovascular disease risk profiles. This increased risk became apparent after the age of 40 years. Our results indicate an increased prevalence of hypertension and overall more unfavourable CVD risk profiles in haemophilia patients compared with the general age-matched male population.

Entities:  

Mesh:

Year:  2012        PMID: 23138324     DOI: 10.1160/TH12-05-0332

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

Review 1.  Current concepts in the management of stable ischemic heart disease and acute coronary syndrome in patients with hemophilia.

Authors:  Ahmad Y Jabbar; Hassan Baydoun; Maissaa Janbain; Keith C Ferdinand
Journal:  Ann Transl Med       Date:  2018-08

2.  Risk factors for cardiovascular disease in children and young adults with haemophilia.

Authors:  Jacqueline Limjoco; Courtney D Thornburg
Journal:  Haemophilia       Date:  2018-07-13       Impact factor: 4.287

3.  A cross-sectional analysis of cardiovascular disease in the hemophilia population.

Authors:  Suman L Sood; Dunlei Cheng; Margaret Ragni; Craig M Kessler; Doris Quon; Amy D Shapiro; Nigel S Key; Marilyn J Manco-Johnson; Adam Cuker; Christine Kempton; Tzu-Fei Wang; M Elaine Eyster; Philip Kuriakose; Annette von Drygalski; Joan Cox Gill; Allison Wheeler; Peter Kouides; Miguel A Escobar; Cindy Leissinger; Sarah Galdzicka; Marshall Corson; Crystal Watson; Barbara A Konkle
Journal:  Blood Adv       Date:  2018-06-12

Review 4.  Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B.

Authors:  Victor A Ferraris; Leonard I Boral; Alice J Cohen; Susan S Smyth; Gilbert C White
Journal:  Cardiol Rev       Date:  2015 Mar-Apr       Impact factor: 2.644

Review 5.  Comorbidities of cardiovascular disease and cancer in hemophilia patients.

Authors:  Jiaan-Der Wang
Journal:  Thromb J       Date:  2016-10-04

6.  A second retrospective database analysis confirms prior findings of apparent increased cardiovascular comorbidities in hemophilia A in the United States.

Authors:  Thomas J Humphries; Alice Ma; Craig M Kessler; Rajesh Kamalakar; Jennifer Pocoski
Journal:  Am J Hematol       Date:  2016-04-07       Impact factor: 10.047

7.  Peri-cardiac surgery coagulation management in a severe hemophilia A patient: A case report.

Authors:  Hongfei Xu; Davies Henry; Chengcheng Li; Haige Zhao; Yanyan Yang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study.

Authors:  Richard F W Barnes; Thomas J Cramer; Afrah S Sait; Rebecca Kruse-Jarres; Doris V K Quon; Annette von Drygalski
Journal:  Int J Hypertens       Date:  2016-11-14       Impact factor: 2.420

9.  The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment.

Authors:  Christian Qvigstad; Robert Campbell Tait; Stephan Rauchensteiner; Erik Berntorp; Philippe de Moerloose; Roger E Schutgens; Pål Andre Holme
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

10.  Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001-2018.

Authors:  Shermarke Hassan; Rory C Monahan; Evelien P Mauser-Bunschoten; Lize F D van Vulpen; Jeroen Eikenboom; Erik A M Beckers; Louise Hooimeijer; Paula F Ypma; Laurens Nieuwenhuizen; Michiel Coppens; Saskia E M Schols; Frank W G Leebeek; Cees Smit; Mariëtte H Driessens; Saskia le Cessie; Erna C van Balen; Frits R Rosendaal; Johanna G van der Bom; Samantha C Gouw
Journal:  J Thromb Haemost       Date:  2020-12-18       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.